Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound   Target Concepts: Gene/Protein Disease Symptom Drug Enzyme Compound

---

Query: EC:2.7.10.2 (focal adhesion kinase)
44,029 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

More patients were hospitalised for acute salpingitis at the Department of Obstetrics and Gynaecology, Orebro Medical Centre, Orebro, Sweden, during the 5 year period 1970-1974 (period I) as compared with that of 1980-1984 (period II), 666 patients and 524 respectively, a decrease of 22%. The majority of cases, 92% in period I and 85% in period II, occurred among women 15-34 years of age, that is a relative increase of patients aged over 34 from 8% in period I to 15% in period II. Concomitant urogenital gonorrhoea occurred in 26.2% of the patients in period I compared with 12.0% in period II, a highly significant decrease (p less than 0.001) mainly confined to the age group 15-24, whereas there was no relative difference for the two periods in the age group 25-34 years. The number of patients using intrauterine contraceptive device (IUCD) was 96/666 (14.4%) in period I compared with 113/524 (21.6%) in period II (p less than 0.001). There were also relatively more IUCD users among the patients with gonorrhoea and acute salpingitis in period II (15.5%) compared with period I (10.4%) but this difference was not statistically significant. From 1981 to 1984 370/424 patients were cultured for Chlamydia trachomatis and 27.8% (103/370) were positive. Thus Chlamydia trachomatis is at present, at least in the Orebro area, the most frequently isolated STD agent among acute salpingitis patients while gonorrhoea is of much less importance.
...
PMID:Epidemiology and aetiology of acute non-tuberculous salpingitis. A comparison between the early 1970s and the early 1980s with special reference to gonorrhoea and use of intrauterine contraceptive device. 224 78

The diagnostic value of different laboratory methods in detecting Chlamydia trachomatis infections in high risk groups was analysed. The efficiency of a direct specimen test was compared with serology (IgG and IgM ELISA) and culture in L929 cells, stained either with fluorescein conjugated monoclonal antibodies or with iodine. Patients (no. = 1041) with localized genital infections attending a STD clinic, sexual contacts and patients with ascending infections from urological and gynecological clinics were examined. Chlamydia trachomatis was detected in 225 patients: 210 (93.3%) were reactive in the direct test (smears stained with monoclonal antibodies), whereas culture missed only 5 (sensitivity 97.8%) when stained by the same method. Cultures stained with iodine produced the lowest recovery rate (73.8%), but this rate increased to 80.9% when a second passage was performed. In addition the prevalence of Neisseria gonorrhoeae, Mycoplasma hominis, Ureaplasma urealyticum, Candida albicans and Trichomonas vaginalis was investigated. In patients with non-gonococcal urethritis (no. = 331) and cervicitis (no. = 353), Chlamydia trachomatis was isolated in 32.3% and 12.8% respectively. However, this pathogen could be isolated in only 3 (15.8%) out of 19 patients with epididymitis and 15 (14%) out of 107 patients with adnexitis, although 66.7% and 93.3% respectively had specific IgG antibodies. Specific IgM could by detected with a sandwich ELISA in patients with adnexitis (46.7%), epididymitis (33.3%), cervicitis (22.2%), non-gonococcal urethritis (14%) and in the sexual partners of patients with genital infections (35.7%). The direct specimen test with monoclonal antibodies is the method of choice for the diagnosis of a C. trachomatis infection in patients with urethritis and cervicitis.(ABSTRACT TRUNCATED AT 250 WORDS)
...
PMID:Diagnosis of Chlamydia trachomatis infection--culture versus serology. 245 16

We searched in 100 healthy pregnant women by isolation, the presence of Neisseria gonorrhoeae, Herpes simplex, Mycoplasma hominis, Ureaplasma urealyticum and Chlamydia trachomatis. Blood was also taken for examination of specific antibodies to these microorganisms. We studied only for antibodies titled Cytomegalovirus (CMV), Treponema pallidum and Human Immunodeficiency Virus, and Condyloma acuminatum by cervical cytology. In 85 adolescents we found 5 (6%) patients with C. trachomatis, four of these patients had another microorganism added, one with N. gonorrhoeae, M. hominis and U. Urealyticum, one with U. urealyticum and the last two with M. hominis and U. urealyticum, In relation to Mycoplasmas 69 (81%) out of 85 had Mycoplasmas, 4 (5%) had M. hominis, 46 (54%) U. urealyticum and 19 (22%) patients had both. The seropositivity to CMV was 96.25%. We didn't find any other microorganism. We concluded that the rate of STD in chilean pregnant adolescent women is high, especially with no traditional bacteria.
...
PMID:[Diagnosis of sexually transmitted diseases in Chilean pregnant adolescents]. 249 Jan 69

A standard cost-finding methodology was used to estimate the incremental expenses associated with the provision of screening, diagnostic and treatment services for N. gonorrhoeae and Chlamydia trachomatis in a family planning clinic serving high risk adolescents. The study included both the personnel and nonpersonnel costs accrued in administering screening and diagnostic tests, contacting patients with infection, treating patients with infection, and administering tests of cure. The cost per screening test averaged $9.74 when part of a routine family planning visit. Diagnostic tests provided to drop-ins with symptoms averaged $19.92. Treatment-related costs per visit averaged $24.97. The total incremental cost of providing STD screening, diagnosis, and treatment services in the clinic represented 14% of the clinic's overall budget during the study period.
...
PMID:The incremental cost of screening, diagnosis, and treatment of gonorrhea and chlamydia in a family planning clinic. 250 Jul 21

The Hawaii State Department of Health's Chlamydia Network Project screened 272 asymptomatic females for chlamydia; 20 (7.4 per cent) were found to be positive. When interviewed, 75 per cent (15/20) of the cases gave information such that their sexual partner(s) could be located. Ninety per cent (14/16) of the locatable partners were brought to examination within seven days. Keys to success were the training of family planning clinic staff in STD (sexually transmitted disease) control methods, and close intra-agency cooperation.
...
PMID:The Hawaii Chlamydia Network Project: a successful program incorporating close intra-agency cooperation. 292 15

From January through March of 1985, the Sapporo Clinical Research Group for STD treated 69 cases of gonococcal infections (61 cases of male gonococcal urethritis and 8 cases of female gonococcal cervicitis) at its facilities in Sapporo City. The therapeutic efficacy of one shot therapy of Spectinomycin (SPCM) was investigated, and an epidemiological study on the cases and bacteriological studies on the isolated strains of Neisseria gonorrhoeae were made. The male patients were between 19 and 55 years old, with a peak age distribution in the younger half of the twenties. The female patients were between 18 and 40 years old. The major source of infections was a so-called special massage parlor which accounted for 36.1% of male cases. The isolation rate of PPNG were 16.7% (11/66). The MIC (inoculum size; 10(6) CFU/ml) of SPCM ranged from 3.13 to 25 micrograms/ml regardless of beta-lactamase production. In male patients, the eradication rate (efficacy rate) of N. gonorrhoeae by SPCM was 94.7% on the first day, 93.6% on the third day and 100% on the seventh day after 2 g one shot therapy. In female patients, the rate was 100% on the third and seventh day after 2 g one shot therapy, and 75% on the first day, 66.7% on third day and 100% on seventh day after 4 g one shot therapy. We considered that one shot therapy of SPCM was effective for gonococcal infection also in the present time. Especially SPCM was effective for infections by PPNG, since it was not resolved by beta-lactamase of N. gonorrhoeae. Positive rate of Chlamydia trachomatis was 16.3% in male gonococcal urethritis, and the serous discharge tended to remain longer in the positive patients than in the negative patients. There was only one side effect (1.4%), therefore SPCM was recognized to be a safely administrated antimicrobial agent.
...
PMID:[Epidemiological and therapeutic studies on gonococcal infections--one shot therapy by spectinomycin--[Sapporo Clinical Research Group for STD]]. 295 80

In 589 males, 169 with and 420 without urethritis, urethral swabs were taken and assessed semiquantitatively for the sexually transmittable infectious agents Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis and Candida species. The organisms were isolated in patients with and without urethritis as follows: N. gonorrhoeae with urethritis 19.5%, without 0.0%; C. trachomatis with urethritis 16.0%, without 2.9%; U. urealyticum (high cfu-counts) with urethritis 27.2%, without 11.7%; M. hominis (high cfu) with 4.7%, without 2.9%. Combined infections were more frequent in males with urethritis (20.8%) than in those without (5.4%). None of the investigated pathogenic microorganisms could be demonstrated in 37.9% of males with and in 71.2% of males without urethritis. Using loglinear analysis, a significant coincidence of infections with N. gonorrhoeae and U. urealyticum and of infections with U. urealyticum and M. hominis was found. It is concluded that an asymptomatic infection of the male urethra with sexually transmittable organisms is to be expected in partner's control examinations and in patients presenting for other STD like venereal warts or genital herpes. Therefore in these men, even if they are asymptomatic, a comprehensive microbiological examination is strongly recommended.
...
PMID:Sexually transmittable organisms in the urethra of males with and without urethritis. 311 95

A total of 440 women under 28 weeks' gestation comprising 257 Fijians and 183 Indians attending the antenatal clinic at the Anderson Maternity Unit in Suva, Fiji, between November, 1985, and April, 1986, were selected for the study on their first visit. After an obstetric history was taken and a general physical examination performed, specimens for microbial studies were collected from the cervix and the posterior vaginal fornix. Blood was collected for serological tests for syphilis. Neisseria gonorrhea was identified on colonial morphology, Gram stain and oxidase reactivity. Specimens for Chlamydiazyme immunoassay test were stored at 40 C and tested within 5 days of collection. Tests for syphilis were performed using Venereal Disease Research Laboratory (VDRL) and treponema pallidum hemagglutination (TPHA) tests. Results for chlamydia are available for only 244, as this was introduced midway in the study. All STD pathogens were isolated in significantly higher rates from Fijian compared to Indian women p 0.01). Chlamydia trachomatis was the most common agent, affecting 50% of Fijian women and 37.5% of Indian women. Candida albicans was the next most common pathogen in both groups, accounting for 40%. Trichomonas vaginalis was found in 8.2% of both groups. N gonorrhea was isolated in 2.3% of the population studied. The average age of women with gonorrhea was 22 years, whereas the average age of the whole population studied was 26.1 years. They were also predominantly single or living in a consensual relationship. Group B beta hemolytic streptococci were identified in only 9 of the 440 women studied. Serological tests were interpreted to be positive for syphilis if both VDRL and TPHA were positive in the absence of a history of previous treatment for syphilis. The difference in infection rates of 14.2% for Fijians and 1.7% for Indians was highly significant (p 0.01).
...
PMID:The prevalence of sexually transmitted disease agents in pregnant women in Suva. 312 3

In a prospective study, urethral swabs were taken from 544 men presented to an STD clinic, 118 with and 426 without urethritis, and examined by microscope and/or culture for G. vaginalis, Chlamydia trachomatis, Neisseria gonorrhoeae, Ureaplasma urealyticum, Mycoplasma hominis, Candida species and Trichomonas vaginalis. G. vaginalis was isolated from 4.2% of the males with urethritis and from 6.3% of those without urethritis. Using loglinear analysis, the following associations were significant (p less than 0.05): three-way: G. vaginalis, U. urealyticum, C. trachomatis; two-way: G. vaginalis, U. urealyticum and G. vaginalis, M. hominis and U. urealyticum, M. hominis. It is concluded that G. vaginalis is associated with genital mycoplasmas not only in the female, but also in the male urogenital tract.
...
PMID:Gardnerella vaginalis is associated with other sexually transmittable microorganisms in the male urethra. 314 May 32

Most pregnant women who have Chlamydia trachomatis (C. trachomatis) in the uterine cervix are asymptomatic. Several ways of detecting C.trachomatis were tested on 331 pregnant women, as well as 146 female patients attending our STD clinic as a control. 1) The detection rates for C.trachomatis in the cervix of pregnant women were 5.1% using the cell culture method, 2.4% with Micro Trak, and 2.2% employing Chlamydiazyme. These rates were higher in those patients visiting the STD clinic. 2) In pregnant women, the positive rate of Chlamydiazyme was 66.7% in the cell culture-positive cervical specimens, whereas Micro Trak was positive in 33.3%. 3) The antibody-positive rate was 84.6% in cases with PID caused by C.trachomatis. The antibody was found in only 17.7% of the pregnant women. Additionally, no significant correlation was noted between the antibody titer and C.trachomatis colonization in specimens obtained from the cervix of pregnant women. Although Micro Trak, Chlamydiazyme and possibly the microplate immunofluorescence antibody technique can be substituted for a cell culture method for detecting C.trachomatis in cases of symptomatic infection, these tests are not considered to be useful for screening Chlamydia-positive pregnant women.
...
PMID:[Detection of Chlamydia trachomatis by several methods in the uterine cervix of pregnant women]. 336 Nov 74


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>

---